Filter Results
:
(140)
Show Results For
-
All HBS Web
(334)
- People (1)
- News (131)
- Research (140)
- Multimedia (13)
- Faculty Publications (84)
Show Results For
-
All HBS Web
(334)
- People (1)
- News (131)
- Research (140)
- Multimedia (13)
- Faculty Publications (84)
Sort by
- 04 Apr 2022
- Research & Ideas
Tech Hubs: How Software Brought Talent and Prosperity to New Cities
period. Software is penetrating other industries, Kerr notes. Take vaccines. Pharmaceutical companies’ speedy development of mRNA-based vaccines for COVID-19 required software, he notes. “Their capacity to bring a substantial software, AI...
View Details
Keywords:
by Rachel Layne
- 19 May 2021
- Op-Ed
Why America Needs a Better Bridge Between School and Career
Over a year into the COVID-19 pandemic, there are hints of optimism as more people gain access to vaccines and the federal government injects more stimulus money into the economy. Yet, the outlook for workers remains mixed. The crisis has...
View Details
Keywords:
by Joseph B. Fuller and Rachel Lipson
- 19 Jul 2017
- Research & Ideas
Why Government 'Nudges' Motivate Good Citizen Behavior
other categories. A nudge on energy conservation that compared households to their neighbors led to almost twice as many kilowatt-hours saved per dollar spent as traditional education and incentives. A nudge to schedule flu shots led to almost a 50 percent increase in...
View Details
Keywords:
by Michael Blanding
- 13 Sep 2021
- Research & Ideas
Science: The Unlikely Frontier for New Business Ideas
operations after a year of uncertainty due to COVID-19, Krieger points to the science labs that never stopped—and some that worked overtime, such as companies like Moderna that produced vaccines in record time. He sees lots more...
View Details
Keywords:
by Avery Forman
- 13 Jan 2021
- Research & Ideas
How 'Small C' Change Can Beat Large-Scale Rebuilding
Even as COVID vaccines begin early deployment, pressure on leaders continues to mount to engage in “Big C” change: rapid course corrections through job cuts, recruiting a fresh management team, and redesigning roles and responsibilities...
View Details
- 28 May 2020
- Research & Ideas
Coronavirus Could Create a 'Bankruptcy Pandemic'
equity firms have billions of dollars of investible cash—although whether any of these investors have the appetite to risk their capital in the present environment is yet to be determined. And of course, an effective cure or vaccine for...
View Details
- 17 Mar 2021
- Research & Ideas
Beyond Pajamas: Sizing Up the Pandemic Shopper
significantly as more consumers than ever started shopping online. As vaccines fuel hope about life after COVID-19, retailers are trying to learn more about the pandemic shopper. Are they different from the existing online users? Do they...
View Details
- 19 Jan 2022
- In Practice
7 Trends to Watch in 2022
As 2022 gets underway we asked our faculty to highlight some trends worth watching in the coming year. Ariel Stern: A new future for digital health care While 2020 and 2021 were years of rapid innovation and deployment of new health care technologies and delivery...
View Details
Keywords:
by HBS News
- 14 Dec 2020
- Research & Ideas
What Does December's Drug-Approval Dash Mean for COVID-19 Vaccines?
Pharmaceutical regulators around the world tend to speed through drug applications in December and before major national holidays, according to new research that might raise questions about COVID-19 vaccines and other treatments under...
View Details
- 25 Oct 2004
- Research & Ideas
Planning for Surprises
still awaits. We stick by our recommendation: Use your miles! Q: What other looming, predictable surprises have you noticed since the book manuscript was completed? A: The flu vaccine crisis is a classic example of a predictable surprise....
View Details
Keywords:
by Martha Lagace
- 09 Sep 2014
- First Look
First Look: September 9
patient. Schrader and his colleagues had to decide on which vaccines to focus and whether and how to target the drug companies that manufactured the vaccines or the quasi-government organizations (such as...
View Details
Keywords:
Sean Silverthorne
- 11 May 2020
- Op-Ed
Immigration Policies Threaten American Competitiveness
It is no secret that immigration has reshaped American innovation. Immigrants are the backbone of America’s most innovative industries, provide a quarter of our patent applications, and are numerous among our science and engineering superstars. Taken from World...
View Details
Keywords:
by William R. Kerr
- 02 Sep 2014
- First Look
First Look: September 2
Harvard Business School Case 514-074 Sanofi Pasteur: The Dengue Vaccine Dilemma In 2012, Sanofi Pasteur was racing to develop a vaccine against dengue, a mosquito-borne disease, and was evaluating this...
View Details
Keywords:
Sean Silverthorne
- 15 May 2020
- Research & Ideas
Find Your Pragmatic Path through Radical Uncertainty
virus will give us the answers.” Will contracting the disease provide immunity? How long will immunity last? When will a successful vaccine be widely available? What will be an acceptable vaccine trial? How...
View Details
- 20 May 2016
- Op-Ed
World Health Organization Lacks Leadership to Combat Pandemics
greater role in WHO governance and if there are guarantees of purchase contracts for new drugs and vaccines at sensible prices. Both seem unlikely, as the WHO's culture has always winced at cooperation with the private sector. WHO's track...
View Details
- 06 May 2019
- Research & Ideas
Consumers Blame Business for Global Health Problems. Can Business Become the Solution?
to appeal to young would-be smokers. But corporate distrust runs so deep for some consumers that constructive dialogue is virtually impossible; consider vaccination skeptics who criticize Big Pharma’s influence, despite considerable...
View Details
- 12 Dec 2022
- Research & Ideas
Buy-In from Black Patients Suffers When Drug Trials Don’t Include Them
Moderna, a pharmaceutical company, announced in September 2020 that it would slow enrollment of its COVID-19 vaccine trials to better improve representation. The majority of study participants were white, although COVID-19 was...
View Details
- 17 Feb 2021
- Research & Ideas
Pandemic Self-Care for CEOs: Rituals, Running, and Cognitive Restructuring
which a successful vaccine was developed; and the inherent sense of rebirth and freedom that comes with spring blend into a potent psychological cocktail. All of these things are, of course, legitimate cause for celebration and...
View Details
- 17 Dec 2020
- Research & Ideas
The 10 Most Popular Stories of 2020
reader interest in an interview with Merck CEO Ken Frazier, who talked candidly about prospects for COVID-19 vaccines and racism in the workplace. Here are our most popular articles, research papers, and social media posts of 2020. In the...
View Details
Keywords:
by Dina Gerdeman
- 07 Aug 2012
- First Look
First Look: August 7
case:http://hbr.org/search/812158-PDF-ENG GlaxoSmithKline in Brazil: Public-Private Vaccine Partnerships Arthur A. Daemmrich and Ian McKown CornellHarvard Business School Case 712-049 Three years into a major public-private partnership...
View Details
Keywords:
Sean Silverthorne